High-Intensity Interval Training for Type 2 Diabetes
(FHT HIIT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment High-Intensity Interval Training for Type 2 Diabetes?
Research shows that high-intensity interval training (HIIT) can improve blood sugar control and heart fitness in people with type 2 diabetes. It is also a time-efficient way to manage risk factors for heart and metabolic diseases, making it a practical option for those who struggle to meet traditional exercise guidelines.12345
Is high-intensity interval training (HIIT) generally safe for humans?
HIIT is generally well-tolerated and may offer health benefits, but caution is advised for people with heart and metabolic conditions. They should be stable, have some exercise experience, and be supervised during sessions. No acute injuries were reported in most studies, and adherence rates were high.36789
How does high-intensity interval training differ from other treatments for type 2 diabetes?
What is the purpose of this trial?
With the rapid shift to virtual care, this pilot study aims to determine the feasibility of prescribing low-duration, interval-based training through virtual care. If successful, this study will inform a larger randomized control trial to determine if the prescription of low-duration interval-based training improves chronic disease through the measurement of hemoglobin A1C (HbA1C), and weight to a greater extent than the general guideline to aim for 150 minutes of PA weekly.
Eligibility Criteria
This trial is for adults over 18 with type 2 diabetes who can safely exercise and have their doctor's (Dr. Fernando) approval. They must be able to consent and should not be pregnant or have had a heart attack in the last three months.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Data collection at baseline including weight, height, minutes of PA, HbA1C, and medication review
Intervention
Participants follow either a high-intensity interval training (HIIT) or population-based physical activity protocol
Follow-up
Participants are monitored for changes in HbA1C, weight, and physical activity at 3-month and 6-month intervals
Treatment Details
Interventions
- High-Intensity Interval Training Physical Activity (PA) Advice
Find a Clinic Near You
Who Is Running the Clinical Trial?
Western University, Canada
Lead Sponsor
East Elgin Family Health Team
Collaborator